Xeber.world
FDA Commissioner Marty Makary resigns after months of internal scrutiny, with Kyle Diamantas stepping in as acting commissioner. Meanwhile, Eli Lilly'...
A new Rice University study finds that people who lose weight using GLP-1 medications like Ozempic face greater judgment than those who regain weight...
Novo Nordisk’s new weight-loss pill, Wegovy, has achieved 1.3 million prescriptions in Q1 2026, prompting the company to raise its full-year guidance....
Medicare will launch a pilot program in July 2026 offering GLP-1 weight loss drugs like Wegovy and Zepbound for $50 per month. The initiative, running...
France’s medicines regulator has fined Novo Nordisk $2 million and Eli Lilly $127,000 for allegedly misleading advertisements for their weight loss dr...
The FDA has proposed excluding semaglutide and tirzepatide, key ingredients in popular weight-loss and diabetes drugs like Wegovy, Ozempic, Mounjaro,...
A new study suggests tirzepatide medications like Mounjaro may lead to greater lean body mass loss compared to semaglutide drugs like Ozempic. Researc...
The Trump administration proposed a Medicare pilot program to offer discounted weight loss drugs to seniors, but insurers declined participation. As a...